Flu Vaccine for Secondary Prevention of Coronary Events

Published Online: Tuesday, March 22, 2011
Follow Pharmacy_Times:
This video presentation discusses the results of a new study that provides further evidence that influenza vaccine reduces major cardiovascular events in patients hospitalized for acute coronary syndrome.

Click here to access this third-party resource.
Related Articles
Last year’s flu vaccine efficacy was less than desirable, so pharmacists may have to work harder this year to encourage patients to get immunized again.
The FDA has approved the Flublok influenza vaccine formulation for the 2015-2016 flu season.
The FDA is investigating potential risks associated with codeine-containing medicines to treat coughs and colds in children aged under 18 years.
Pennsylvania pharmacists can provide flu shots to children under a new law signed by Governor Tom Wolf.
Latest Issues
$auto_registration$